BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6245897)

  • 1. Effects of captopril (SQ 14, 225) on the renin-angiotensin-aldosterone system in normal rats.
    Kokubu T; Ueda E; Ono M; Kawabe T; Hayashi Y; Kan T
    Eur J Pharmacol; 1980 Apr; 62(4):269-75. PubMed ID: 6245897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An experimental study on the effects of the chronic administration of an angiotensin converting enzyme inhibitor (captopril) on blood pressure and the renin-angiotensin-aldosterone system (author's transl)].
    Goto A
    Nihon Naibunpi Gakkai Zasshi; 1980 Jun; 56(6):868-83. PubMed ID: 6997093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
    Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of captopril on serum angiotensin-converting enzyme activity, the renin-aldosterone system and blood pressure in patients with sarcoidosis.
    Mizuno K; Gotoh M; Matsui J; Nagasawa S; Fukuchi S
    Tohoku J Exp Med; 1983 May; 140(1):107-8. PubMed ID: 6306866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of captopril on brain converting enzyme in the spontaneously hypertensive rat.
    Di Nicolantonio R; Mendelsohn FA; Hutchinson JS; Doyle AE
    Clin Exp Pharmacol Physiol; 1984; 11(3):237-44. PubMed ID: 6086193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers.
    Shepherd AN; Campbell BC; Reid JL
    J Cardiovasc Pharmacol; 1982; 4(3):381-7. PubMed ID: 6177933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a single administration of captopril on hemodynamics and serum angiotensin converting enzyme activity, plasma renin activity and plasma aldosterone concentration in hypertensive patients.
    Hashimoto H; Hiwada K; Kokubu T
    Jpn Circ J; 1981 Feb; 45(2):176-80. PubMed ID: 6262543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Captopril in the long-term treatment of essential hypertension: changes in the renin-angiotensin-aldosterone system.
    Riegger GA; Steilner H; Hayduk K; Liebau G
    Am J Cardiol; 1982 Apr; 49(6):1555-7. PubMed ID: 6803566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The changes in renin-angiotensin-aldosterone system in acute myocardial infarction and the effects of converting enzyme inhibitor-captopril].
    Jiang M
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):342-4, 396. PubMed ID: 1668233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril.
    Waeber B; Brunner HR; Brunner DB; Curtet AL; Turini GA; Gavras H
    Hypertension; 1980; 2(2):236-42. PubMed ID: 6247269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic administration of captopril on blood pressure and the renin-angiotensin-aldosterone system in normotensive rats.
    Ishii M; Goto A; Kimura K; Hirata Y; Yamakado M; Takeda T; Murao S
    Jpn Heart J; 1983 Jul; 24(4):623-31. PubMed ID: 6358579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose response in captopril therapy of hypertension.
    Lijnen P; Fagard R; Staessen J; Verschueren LJ; Amery A
    Clin Pharmacol Ther; 1980 Sep; 28(3):310-5. PubMed ID: 6250759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of angiotensin converting enzyme inhibitor on serum aldosterone and potassium level.
    Kamei H; Arakawa K
    Jpn Heart J; 1982 Mar; 23(2):191-9. PubMed ID: 7043022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral and hemodynamic effects of increasing doses of captopril in patients with essential hypertension.
    Sassano P; Pedrinelli R; Magagna A; Abdel-Haq B; Salvetti A
    Am J Cardiol; 1982 Apr; 49(6):1574-6. PubMed ID: 6280486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of time and dose on angiotensin converting enzyme during captopril treatment in the rat.
    Forslund T
    Acta Pharmacol Toxicol (Copenh); 1983 Mar; 52(3):201-4. PubMed ID: 6303049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of angiotensin I-converting enzyme rat lung with Captopril (SQ 14225).
    Fyhrquist F; Forslund T; Tikkanen I; Grönhagen-Riska C
    Eur J Pharmacol; 1980 Oct; 67(4):473-5. PubMed ID: 6256177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study.
    Lee AF; MacFadyen RJ; Struthers AD
    Eur J Heart Fail; 1999 Dec; 1(4):401-6. PubMed ID: 10937954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.